University of California San Francisco
Give to UCSF
55% of seniors with dementia take more than six medications even though most have good health. However, a UCSF study showed that 87% are willing to cut down if their doctors agree.
Concussion may have a long-term impact on cognition, a new UCSF-led study finds. Fourteen percent of patients had "poor cognitive outcome" one year post injury, with car collisions being the leading cause of concussion.
UCSF researchers have developed a digital tool to flag early reading challenges that may lead to dyslexia, and it could be in widespread use in California public schools by 2023. Governor Gavin Newsom is proposing $10 million in the state budget for the project.
A UCSF-led study found a new drug for ALS that shows to slow or temporarily stall the progression of ALS in a select group of patients, with three times as many patients' disease slowing compared to those who received a placebo.
A new “atlas” of every cell in the brain’s blood vessels reveals that some strokes are caused by immune cells interacting with arteries, in a new study by UCSF researchers.
UCSF researchers used multiple drug analogs to test CSF1R inhibition in transgenic mice with tauopathy, and observed suppressed biomarkers of neurodegeneration, rescued aberrant behavior, and extended survival in female mice.
Many patients with COVID-19 develop brain fog and other cognitive symptoms months later. Their cerebrospinal fluid may hold clues to why this is happening.
Human vocal sounds have the same rhythmic quality as the sounds made by many mammals, songbirds, and even some species of fish. UCSF researchers have found the brainstem circuit responsible, and it's connected breath control.
UCSF researchers show how physical activity protects cognition by altering brain chemistry that maintains synapses, especially for the elderly.
Brain maps and developmental outcomes differ greatly in newborns with two of the most common brain injury types, which may have implications for early intervention.
UCSF neurologist Gil Rabinovici, MD, explains the controversy and shares why he thinks Alzheimer’s care is entering a new era “regardless of whether aducanumab proves to be a blockbuster or a bust.”
UCSF’s David Julius won the 2021 Nobel Prize in Physiology or Medicine for his work on pain sensation. “It was really a shock,” he says.
